NASDAQ:DERM Journey Medical (DERM) Stock Price, News & Analysis $6.24 -0.10 (-1.58%) As of 02:29 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Journey Medical Stock (NASDAQ:DERM) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Journey Medical alerts:Sign Up Key Stats Today's Range$6.15▼$6.4650-Day Range$4.86▼$6.3552-Week Range$4.31▼$9.56Volume117,128 shsAverage Volume203,839 shsMarket Capitalization$171.79 millionP/E RatioN/ADividend YieldN/APrice Target$13.00Consensus RatingHold Company Overview Journey Medical Corp, headquartered in Fairfield, New Jersey, is a commercial dermatology company focused on acquiring, developing and marketing prescription dermatology products in the United States. Since its incorporation in 2019, the company has built a portfolio of both branded and generic topical therapies designed to address a range of skin conditions, including acne, atopic dermatitis, fungal infections and inflammatory lesions. The company’s product lineup features antibiotic/anti-inflammatory combinations and corticosteroid-based formulations delivered through proprietary gel, cream and foam vehicles. Journey Medical leverages an in-house commercial infrastructure, including a specialized sales force and key partnerships with pharmacies and distributors, to reach dermatology practices and healthcare providers nationwide. Underpinning its growth strategy is an acquisition-driven approach that targets established, off-patent dermatology assets with stable prescription demand. The company’s management team, comprised of executives with deep experience in pharmaceutical marketing and specialty drug launches, continues to screen for complementary assets to expand its addressable market and enhance shareholder value.AI Generated. May Contain Errors. Read More Journey Medical Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks47th Percentile Overall ScoreDERM MarketRank™: Journey Medical scored higher than 47% of companies evaluated by MarketBeat, and ranked 585th out of 855 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingHold Consensus RatingJourney Medical has received a consensus rating of Hold. The company's average rating score is 2.25, and is based on no strong buy ratings, 2 buy ratings, 1 hold rating, and 1 sell rating.Upside PotentialJourney Medical has a consensus price target of $13.00, representing about 110.1% upside from its current price of $6.19.Amount of Analyst CoverageJourney Medical has only been the subject of 2 research reports in the past 90 days.Read more about Journey Medical's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth752.94% Earnings GrowthEarnings for Journey Medical are expected to grow by 752.94% in the coming year, from $0.17 to $1.45 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Journey Medical is -16.70, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Journey Medical is -16.70, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioJourney Medical has a P/B Ratio of 6.45. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Journey Medical's valuation and earnings. Short Interest0.0 / 5Short Interest LevelBearish Percentage of Shares Shorted15.02% of the float of Journey Medical has been sold short.Short Interest Ratio / Days to CoverJourney Medical has a short interest ratio ("days to cover") of 14.21, which indicates bearish sentiment.Change versus previous monthShort interest in Journey Medical has recently increased by 1.35%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldJourney Medical does not currently pay a dividend.Dividend GrowthJourney Medical does not have a long track record of dividend growth. News and Social Media2.2 / 5News Sentiment0.47 News SentimentJourney Medical has a news sentiment score of 0.47. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.84 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Journey Medical this week, compared to 3 articles on an average week.Search InterestOnly 1 people have searched for DERM on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership0.6 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Journey Medical insiders have not sold or bought any company stock.Percentage Held by Insiders14.53% of the stock of Journey Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions7.25% of the stock of Journey Medical is held by institutions.Read more about Journey Medical's insider trading history. Receive DERM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Journey Medical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. DERM Stock News HeadlinesJourney Medical Corporation (NASDAQ:DERM) Given Consensus Recommendation of "Hold" by AnalystsJune 15 at 5:06 AM | americanbankingnews.comJourney Medical (NASDAQ:DERM) Raised to "Buy" at Wall Street ZenJune 13 at 1:16 AM | americanbankingnews.comThe roadshow starts Monday. This stock isn't ready.The SpaceX roadshow kicks off June 8. Goldman Sachs, the lead underwriter, will present the full S-1 to the world's largest fund managers - including a section naming one small company Musk's Colossus cannot operate without. Right now, most fund managers have never heard of it. By Friday, every one of them will. Dylan Jovine has identified the name and ticker before $75 billion in new capital starts chasing the SpaceX supply chain.June 16 at 1:00 AM | Behind the Markets (Ad)Financial Contrast: Journey Medical (NASDAQ:DERM) versus MediWound (NASDAQ:MDWD)June 10, 2026 | americanbankingnews.comHow The Journey Medical (DERM) Investment Narrative Is Evolving With An Unchanged Valuation TargetJune 3, 2026 | uk.finance.yahoo.comJourney Medical Corporation to Participate in A.G.P.’s Annual Virtual Healthcare ConferenceMay 20, 2026 | markets.businessinsider.comJourney Medical Corporation to Participate in A.G.P.'s Annual Virtual Healthcare ConferenceMay 19, 2026 | globenewswire.comJourney Medical Rides Emrosi Surge in Earnings CallMay 14, 2026 | tipranks.comSee More Headlines DERM Stock Analysis - Frequently Asked Questions How have DERM shares performed this year? Journey Medical's stock was trading at $7.71 on January 1st, 2026. Since then, DERM stock has decreased by 19.7% and is now trading at $6.1890. How were Journey Medical's earnings last quarter? Journey Medical Corporation (NASDAQ:DERM) announced its quarterly earnings data on Wednesday, May, 13th. The company reported ($0.08) EPS for the quarter, missing analysts' consensus estimates of ($0.07) by $0.01. The firm earned $15.96 million during the quarter, compared to analyst estimates of $15.47 million. Journey Medical had a negative trailing twelve-month return on equity of 35.57% and a negative net margin of 14.82%. Read the conference call transcript. When did Journey Medical IPO? Journey Medical (DERM) raised $39 million in an initial public offering on Friday, November 12th 2021. The company issued 3,520,000 shares at $10.00-$12.00 per share. Who are Journey Medical's major shareholders? Journey Medical's top institutional investors include Wasatch Advisors LP (7.81%), Pale Fire Capital SE (1.76%), Lazard Asset Management LLC (0.16%) and Bank of New York Mellon Corp (0.14%). Insiders that own company stock include Claude Maraoui, Ramsey Alloush, Lindsay A Md Rosenwald, Justin Adam Smith and Joseph Benesch. View institutional ownership trends. How do I buy shares of Journey Medical? Shares of DERM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Journey Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Journey Medical investors own include Broadcom (AVGO), NVIDIA (NVDA), Arista Networks (ANET), Meta Platforms (META), ServiceNow (NOW), Adobe (ADBE) and AppLovin (APP). Company Calendar Last Earnings5/13/2026Today6/16/2026Next Earnings (Estimated)8/11/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (1m+) 1-Year History Jun 25 Sep 25 Dec 25 Mar 26 Jun 26 DERM's financial health is in the Green zone, according to TradeSmith. DERM has been in this zone for over one month. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED - DRUGS Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:DERM Previous SymbolNASDAQ:DERM CIK1867066 Webjourneymedicalcorp.com Phone480-434-6670FaxN/AEmployees90Year Founded2014Price Target and Rating Average Price Target for Journey Medical$13.00 High Price Target$13.00 Low Price Target$13.00 Potential Upside/Downside+108.7%Consensus RatingHold Rating Score (0-4)2.25 Research Coverage4 Analysts Profitability EPS (Trailing Twelve Months)($0.37) Trailing P/E RatioN/A Forward P/E Ratio36.65 P/E GrowthN/ANet Income-$11.43 million Net Margins-14.82% Pretax Margin-14.73% Return on Equity-35.57% Return on Assets-10.88% Debt Debt-to-Equity Ratio0.74 Current Ratio1.72 Quick Ratio1.47 Sales & Book Value Annual Sales$61.86 million Price / Sales2.77 Cash FlowN/A Price / Cash FlowN/A Book Value$0.96 per share Price / Book6.49Miscellaneous Outstanding Shares27,530,000Free Float23,534,000Market Cap$171.51 million OptionableN/A Beta1.09 Social Links The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report This page (NASDAQ:DERM) was last updated on 6/16/2026 by MarketBeat.com Staff. From Our PartnersDOJ Admits It In Court—Your Cash Can Be Seized Without WarningThe Department of Justice recently argued in court that cash may not be legally your property - raising concer...Priority Gold | SponsoredThis Could Be the Biggest Monetary Shift in 50 YearsTucked inside U.S. Code Title 31, Section 5117 is a provision allowing the Treasury to reprice America's gold ...Americas Gold Company | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredHow to play the Biggest IPO in stock market history!SpaceX is eyeing a near-$2 trillion IPO valuation, and retail investors are already lining up - but early insi...InvestPub | SponsoredRickards Predicts: Trump to buy tiny $2 stock?Jim Rickards believes the Trump administration is about to take a direct stake in a $2 stock sitting on the la...Paradigm Press | SponsoredThis is the worst news for stocks in 50 yearsGoldman Sachs and Morgan Stanley are issuing a rare warning: what's ahead for U.S. stocks could be the worst e...TradeSmith | SponsoredJ.P. Morgan is betting on this coinIt feels like the world just changed overnight. Middle East peace talks are advancing. Geopolitical risk is ev...Crypto 101 Media | SponsoredA 3M Oz. Historical Gold Resource And A Market That Hasn't Caught UpOne Canadian junior explorer controls a gold and copper system in British Columbia's Kootenay Golden Arc - a d...Wall Street Logic | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Journey Medical Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Journey Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DERM Stock Alerts